Providing ultimate value to stakeholders remains key in new style of development.
Ferry Tamtoro
Advertisement
Co-founder and CTO, BrightInsight
Articles by Ferry Tamtoro
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
GSK Enters Multi-Year Collaboration with Helix to Develop Precision Medications
2
Pharmaceutical Executive Daily: Amgen Acquires Dark Blue Therapeutics for $840 Million
3
FDA Limits Regulations on Non-Medical Grade Wearable Fitness Devices
4
Eli Lilly Enters $1.2 Billion Definitive Agreement to Acquire Ventyx Biosciences
5